DSM Sells Special Products to Arsenal Capital

DSM says it has reached an agreement to divest its special products unit to Arsenal Capital Partners (New York), as part of its previously announced vision 2010 strategy, which aims to transform DSM into a life sciences and materials sciences company. The special products deal represents DSM's first divestment related to its transformation program. DSM says it expects to realize operating profit after tax of just more than €10 million ($14.8 million) on the sale, which will be reported as an exceptional item in the income statement. The transaction is...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers